What Happened?
, -based Apellis Appointed Chris Brown as Director GxP audits and supplier management
About the Company
We are a global biopharmaceutical company leveraging courageous science, creativity, and compassion to deliver life-changing therapies. By pioneering targeted C3 therapies, we aim to develop best-in-class and first-in-class therapies for a broad range of debilitating diseases that are driven by uncontrolled or excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.
About the Person
Chris Brown is Director GxP audits and supplier management at Apellis. Previously, Chris held various senior HR leadership roles in the industry.
Info Source
News
Short Profile